Are you yawning too? Know why.. | WeForNews | Latest News, Blogs Are you yawning too? Know why.. – WeForNews | Latest News, Blogs
Connect with us

Health

Are you yawning too? Know why..

Published

on

yawing

New York, Sep 1: Have you ever wondered if you observe another person yawn, you also start to yawn.

It means yawning is contagious because the human propensity triggered automatically by primitive reflexes in a brain area responsible for motor function, a research suggests.

According to researchers, it is a common form of echophenomena – the automatic imitation of another’s words (echolalia) or actions (echopraxia).

And if we try to control yawn it will automatically increases.  And no matter how hard we try to stifle a yawn, it might change the way of yawn but it won’t alter our propensity to yawn.

“This research has shown that the ‘urge’ is increased by trying to stop yourself. Using electrical stimulation we were able to increase excitability and in doing so increase the propensity for contagious yawning,” said Georgina Jackson, a Professor at the University of Nottingham.

“The findings may be important in understanding association between motor excitability and the occurrence of echophenomena in a wide range of conditions linked to increased cortical excitability and/or decreased physiological inhibition such as epilepsy, dementia, autism, and Tourette syndrome,” added Stephen Jackson, a Professor at the varsity.

For the study, the team instructed the volunteers to watch video clips and then either resist yawning or to allow themselves to yawn by using transcranial magnetic stimulation (TMS).

“If we can understand how alterations in cortical excitability give rise to neural disorders we can potentially reverse them. We are looking for potential non-drug, personalised treatments, using TMS that might be affective in modulating imbalances in the brain networks,” Jackson said.

It is found in chimpanzees and dogs as we.

Wefornews Bureau

Disaster

US stocks rally after promising Covid vaccine results from Moderna

Earlier, Moderna’s experimental vaccine, mRNA-1273 which is designed to protect against the Covid-19 virus was generally well tolerated and prompted neutralising antibody activity in healthy adults, say researchers.

Published

on

Vaccine

New York, Jul 15 : The Wall Street on Wednesday cheered the promising early results from US-based pharmaceutical major Moderna’s experimental vaccine, mRNA-1273, and solid earnings from Goldman Sachs Group.

The Dow Jones Industrial Average jumped 338 points in early-morning trading. The S&P 500 rose 1.1 per cent while the Nasdaq Composite advanced 0.9 per cent, reports CNBC.

The three main US stock indexes have recovered most of their losses from the coronavirus-led downturn.

Earlier, Moderna’s experimental vaccine, mRNA-1273 which is designed to protect against the Covid-19 virus was generally well tolerated and prompted neutralising antibody activity in healthy adults, say researchers.

Moderna stocks surged 17.8 per cent to a record high after the news.mRNA-1273 vaccine is designed to induce neutralising antibodies directed at a portion of the coronavirus “spike” protein, which the virus uses to bind to and enter human cells.

In the Phase 1 trial, led by Lisa A Jackson of Kaiser Permanente Washington Health Research Institute in Seattle, the 45 participants ages 18 to 55 years received the candidate vaccine.Three groups of 15 participants received two intramuscular injections, 28 days apart, of either 25, 100 or 250 micrograms (mcg) of the investigational vaccine.

The results from the first stage of Moderna’s vaccine trial showed the first 45 participants developed antibodies to the virus.

The study showed that regarding safety, no serious adverse events were reported. The interim analysis included results of tests measuring levels of vaccine-induced neutralising activity through day 43 after the second injection.

Two doses of vaccine prompted high levels of neutralising antibody activity that was above the average values seen in convalescent sera obtained from persons with confirmed Covid-19 disease.

However, more than half of the participants reported fatigue, headache, chills, myalgia or pain at the injection site. Systemic adverse events were more common following the second vaccination and in those who received the highest vaccine dose.

“The mRNA-1273 vaccine-induced anti-SARS-CoV-2 (coronavirus) immune responses in all participants, and no trial-limiting safety concerns were identified. These findings support further development of this vaccine,” the study authors wrote.

The researchers revealed that Moderna started its phase 2 trial in May and expects to start a phase 3 trial this month.

Russia has claimed to become the first nation to complete clinical trials of Covid-19 vaccine on humans, and the results have proven the medication’s effectiveness, the media reported.

As on Wednesday morning, the overall number of global Covid-19 cases increased to more than 13.2 million, while the death toll soared to over 5,77,000, according to the Johns Hopkins University.

Continue Reading

Disaster

Coronavirus crisis may get ‘worse and worse and worse’, warns WHO

Published

on

Tedros Adhanom Ghebreyesus WHO

GENEVA : The raging coronavirus pandemic has the potential to get far worse if all nations do not adhere to basic healthcare precautions, the World Health Organization (WHO) warned on Monday.

“Let me be blunt, too many countries are headed in the wrong direction, the virus remains public enemy number one,” Director General Tedros Adhanom Ghebreyesus told a virtual briefing from WHO headquarters in Geneva.

“If basics are not followed, the only way this pandemic is going to go, it is going to get worse and worse and worse. But it does not have to be this way.”

Infections rose above 13 million across the world on Monday, according to a Reuters tally, climbing by one million in just five days in a pandemic that has killed more than half a million people.

Continue Reading

Cities

Doctor who managed Goa’s only Covid hospital tests positive

The state currently has more than 900 active Covid-19 cases, with 17 fatalities linked to coronavirus.

Published

on

Dr Gomes

Panaji, July 13 : Dr. Edwin Gomes, who had emerged as the face of Goa”s Covid-19 treatment and care effort, and had served as the in-charge of medication of patients at the state’s only designated Covid-19 hospital, has tested positive for the viral infection, a government spokesperson said.

“Dr. Gomes has been admitted to a state government facility for doctors infected by coronavirus,” the spokesperson said.

Gomes, 58, is also the head of medicine at the state”s only medical college, the Goa Medical College, and had last week ended his unbroken 98-day shift at the designated Covid-19 hospital.

The state currently has more than 900 active Covid-19 cases, with 17 fatalities linked to coronavirus.

Chief Minister Pramod Sawant has said that “four to five” Covid-19 patients who died, were suffering from cancer. “Eight to 10 patients were above the age of 80 years, while one also died of liver failure. The death rate has increased due to co-morbid conditions,” Sawant told reporters at the State Secretariat.

Continue Reading
Advertisement

Most Popular